trending Market Intelligence /marketintelligence/en/news-insights/trending/2r7mLIaAniyk-j9WjpPFnw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Boston Scientific to buy back $1B in outstanding debt

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Boston Scientific to buy back $1B in outstanding debt

Boston Scientific Corp. plans to buy back about $1 billion outstanding debt securities via a cash tender offer.

The tender offer is for up to $1 billion in various outstanding securities including 4.125% senior notes due 2023, 4.000% senior notes due 2028, 3.850% senior notes due 2025 and 3.375% senior notes due 2022.

The tender offers are expected to expire at midnight ET on Nov. 19.

Barclays Capital Inc., BofA Securities and Goldman Sachs & Co. LLC are acting as the lead dealer managers for the transaction.